Publisher Correction: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis

Nat Med. 2021 Aug;27(8):1483. doi: 10.1038/s41591-021-01427-1.

Yuanmeng Jin^#^{1

2}, Krishna Ratnam^#¹, Peter Y Chuang^#¹, Ying Fan¹, Yifei Zhong¹, Yan Dai¹, Amin R Mazloom^{3

4}, Edward Y Chen^{3

4}, Vivette D'Agati⁵, Huabao Xiong⁶, Michael J Ross¹, Nan Chen², Avi Ma'ayan^{7

8}, John Cijiang He^{9

10

11}

¹ Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
² Department of Nephrology, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, China.
³ Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA.
⁴ Systems Biology Center New York (SBCNY), New York, New York, USA.
⁵ Department of Pathology, Columbia University, New York, New York, USA.
⁶ Immunobiology Center, Mount Sinai School of Medicine, New York, New York, USA.
⁷ Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA. [email protected].
⁸ Systems Biology Center New York (SBCNY), New York, New York, USA. [email protected].
⁹ Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA. [email protected].
¹⁰ Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA. [email protected].
¹¹ James J. Peters Veteran Administration Medical Center, New York, New York, USA. [email protected].

^# Contributed equally.

No abstract available

Publication types